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Abstract
TLR2 and TLR4 are crucial for recognition of Chlamydia pneumoniae in vivo, since infected TLR2/4 double-deficient mice are
unable to control the infection as evidenced by severe loss of body weight and progressive lethal pneumonia.
Unexpectedly, these mice display higher pulmonary levels of the protective cytokine IFNc than wild type mice. We show
here, that antigen-specific CD4
+ T-cells are responsible for the observed IFNc-secretion in vivo and their frequency is higher
in TLR2/4 double-deficient than in wild type mice. The capacity of TLR2/4 double-deficient dendritic cells to re-stimulate
CD4
+ T-cells did not differ from wild type dendritic cells. However, the frequency of CD4
+CD25
+Foxp3
+ T-cells was
considerably higher in wild type compared to TLR2/4 double-deficient mice and was inversely related to the number of
IFNc-secreting CD4
+ effector T-cells. Despite increased IFNc-levels, at least one IFNc-mediated response, protective NO-
secretion, could not be induced in the absence of TLR2 and 4. In summary, CD4
+CD25
+Foxp3
+ regulatory T-cells fail to
expand in the absence of TLR2 and TLR4 during pulmonary infection with C. pneumoniae, which in turn enhances the
frequency of CD4
+IFNc
+ effector T-cells. Failure of IFNc to induce NO in TLR2/4 double-deficient cells represents one
possible mechanism why TLR2/4 double-deficient mice are unable to control pneumonia caused by C. pneumoniae and
succumb to the infection.
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Introduction
The obligate intracellular bacterium Chlamydia pneumoniae infects
the respiratory tract and replicates in bronchial epithelial cells
[1,2]. The cells are infected by elementary bodies of C. pneumoniae
which develop within hours post infectionem into reticulate bodies
[1]. The latter form divides several times and within 48 to 72 h a
microscopically visible intracellular inclusion is generated. In vitro,
the replication of C. pneumoniae is impaired by IFNc [3,4]. This
cytokine exerts its effect indirectly via the induction of two
enzymes: the inducible isoform of the nitric oxide synthase (iNOS)
and indolamine 2,3 dioxygenase (IDO). The former enzyme
generates nitric oxide (NO), which is toxic for bacteria and impairs
replication of C. pneumoniae [5], while the latter degrades the
aminoacid tryptophan, which is required by C. pneumoniae [6]. In
vivo, the replication of the bacterium is also controlled by IFNc,a s
chlamydial burden in IFNc receptor-deficient mice is significantly
higher than in wild type mice [7]. Based on these findings it is
obvious that IFNc is crucial to control and confine pneumonia
caused by C. pneumoniae.
The cellular source of IFNc in vivo during pulmonary infection
with C. pneumoniae was analyzed by Rothfuchs et al [8].
Accordingly, NK cells neither contributed to IFNc-secretion by
bronchoalveolar lavage mononuclear cells nor protected mice. In
contrast, IFNc-secreting CD4
+ or CD8
+ T-cells were protective
since they impaired replication of C. pneumoniae. Thus, IFNc-
secreting cells of the adaptive immune system contribute to host
defense against the bacterium.
Innate immune cells like bone marrow derived dendritic
(BMDC) cells recognize C. pneumoniae via TLR2 and 4 [9]. In
contrast to wild type animals, mice double-deficient for TLR2 and
4 were unable to control the replication of the bacteria and
succumbed to progressive pneumonia [10]. Moreover, although
many immune responses in vivo, such as the secretion of pro-
inflammatory cytokines and chemokines, depended almost
exclusively on TLR2, the survival of infected mice required the
presence of TLR2 but also of TLR4 [10]. Unexpectedly, TLR2/4
double-deficient but not TLR2-deficient mice displayed upon
infection with the microorganism significantly higher pulmonary
levels of IFNc than wild type mice [10].
TLRs also influence the adaptive immune response. Thus, mice
lacking MyD88, the most important adapter molecule of the TLR-
signaling cascade, failed to mount a TH1 response upon
immunization with the model antigen ovalbumin in complete
Freund’s adjuvant while antigen-specific TH2 responses were not
impaired [11]. In particular, antigen-specific T-cells from MyD88-
deficient mice were unable to produce IFNc, but secreted TH2
cytokines like IL-13 and IL-4 at least as efficiently as T-cells from
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wild type dendritic cells induced allogeneic CD4
+ T-cells to secrete
IFNc while MyD88-deficient allogenic dendritic cells only
stimulated a TH2 response [12]. However, upon vaccination of
MyD88-deficient mice with Mycobacterium bovis BCG a TH1
response was observed as in wild type mice [13]. Interestingly, the
adaptive immune response induced by the vaccination was only
partially effective to prevent the lethal outcome of a challenging
Mycobacterium tuberculosis infection in MyD88-deficient mice. In
summary, the influence of MyD88 on adaptive immune responses
appears to depend substantially from the model system used.
Here, we explored adaptive immune responses in mice lacking
TLR2 and TLR4 upon pulmonary infection with C. pneumoniae.
The results demonstrate that an increased IFNc-release by the
adaptive immune system in the absence of both TLRs was
associated with a lower frequency of regulatory T-cells. However,
the cytokine was unable to trigger the release of NO by TLR2/4
double-deficient bone marrow-derived macrophages (BMDM).
The latter finding presumably contributes to the increased lethality
observed in TLR2/4 double-deficient mice.
Results
Pulmonary recruitment of T-cells was not impaired in
TLR2/4 double-deficient mice
To explore whether adaptive immune responses were induced in
vivo in the absence of TLR2 and 4 known to be of key importance
for the recognition of C. pneumoniae, we infected wild type and
TLR2/4 double-deficient mice pulmonary with C. pneumoniae.A s
shown in Fig. 1 these TLR-deficient mice lost a considerable part
of their body weight between day 9 and day 12 post infection. In
contrast, this was not observed in wild type mice which displayed a
weaker weight loss between day 0 and 9. Similar data were
demonstrated previously and that study also showed that the
TLR2/4 double-deficient mice succumbed to the infection [10].
While recruitment of polymorphonuclear neutrophils into the
infected lungs was considerably impaired in TLR2/4 double-
deficient mice [10], CD4
+ and CD8
+ T-cells were present in wild
type and TLR2/4 double-deficient mice in similar numbers
(Fig. 2A, B).
Presence of CD4
+IFNc
+ T-cells in the lung of TLR2/4
double-deficient mice
To study whether C. pneumoniae-specific T-cells were detectable
in the infected lung of TLR2/4 double deficient mice, we re-
stimulated T-cells isolated from the lung of infected animals with
wild type BMDC in vitro, which were either infected or not infected
with C. pneumoniae. Intracellular staining for IFNc revealed that the
frequency and absolute number of CD4
+ T-cells producing the
cytokine upon re-stimulation with C. pneumoniae were higher in
TLR2/4 double-deficient when compared to wild type mice
especially day 9 post infection (Fig. 3A, B). Compared to
CD4
+IFNc
+ T-cells, the frequency and absolute number of
IFNc-secreting CD8
+ T-cells were considerably lower in both
Figure 1. TLR2 and 4 are crucial to control pneumonia-induced
loss of body weight of C. pneumoniae-infected mice. Wild type
(n=24 d0, n=18 d6, n=12 d9, n=6 d12) and TLR2/4 double-deficient
mice (n=24 d0, n=18 d6, n=12 d9, n=6 d12) were infected with C.
pneumoniae. At the time point indicated in the graph the body weight
of the mice was determined. Bars represent mean and SD of individual
mice from two independent experiments. *p,0.001, ANOVA posthoc
Holm-Sidak.
doi:10.1371/journal.pone.0026101.g001
Figure 2. Lack of TLR2/4 does not impair pulmonary recruitment of CD4
+ and CD8
+ T-cells upon infection with C. pneumonia. Wild
type (n=3/time point) and TLR2/4 double-deficient mice (n=3/time point) were infected with C. pneumoniae. At the time points indicated in the
graph mice were sacrificed, lungs removed, single cell suspensions were prepared and the number of cells determined. Cells were stained with mAbs
specific for CD4, CD8 and CD3 as described in Materials and Methods, analyzed by flow cytometry and the number of each subpopulation was
calculated. CD4
+CD3
+ T-cells are depicted in (A), CD8
+CD3
+ T-cells in (B). Error bars represent SD of three individual mice.
doi:10.1371/journal.pone.0026101.g002
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enhanced in frequency in the infected TLR2/4 double-deficient
mice. Furthermore, IFNc-secretion by CD4
+ but CD3
2 non T-
cells was barely detectable (Fig. 3C). These results suggested that
antigen-specific TH1 T-cell responses were efficiently generated in
the absence of TLR2 and 4.
Enhanced Chlamydia-specific IFNc-responses in the
absence of TLR2/4 is not confined to the lung
Next, we assessed the local and systemic IFNc-responses from
lung and spleen cells of infected wild type or TLR2/4 double-
deficient mice upon re-stimulation in vitro with C. pneumoniae-pulsed
wild type BMDC. The results revealed that antigen-specific
responses from lung and spleen cells isolated from infected TLR2/
4 double-deficient mice secreted considerably more IFNc than
wild type cells after 3 days in culture (Fig. 4). These findings also
suggested that increased responses by TLR2/4 double-deficient
cells were not confined to the organ infected primarily.
TLR2/4 double-deficient BMDC are capable of stimulating
antigen-specific IFNc-responses
We then explored the capacity of TLR2/4 double-deficient
BMDC to trigger an IFNc response by C. pneumoniae-specific lung
cells. We expected a weaker ability since activation of TLR2-
deficient BMDC upon infection with the bacterium in vitro was
impaired as analyzed by IL-12p40 and TNF secretion and
induction of NF-kB [9]. In vivo, however, the infection induced the
expression of the co-stimulatory molecules CD86 and CD80 as
well as MHC class II by CD11c
+ cells in wild type and TLR2/4
double-deficient mice with comparable efficiency (Fig. 5A, B).
Based on the data presented in Fig. 3 we conclude that TLR2/4
double-deficient antigen-presenting cells triggered primary CD4
+
T cells at least as efficiently as wild type cells. In addition, C.
pneumoniae-infected TLR2/4 double-deficient BMDC re-stimulat-
ed lung cells, which were isolated from C. pneumoniae-infected wild
type mice, as efficiently as wild type BMDC to secrete IFNc
(Fig. 5C). We therefore conclude that a deficiency of TLR2 and
TLR4 by BMDCs did not explain the stronger IFNc-response of
antigen-specific T-cells.
Lungs of TLR2/4 double-deficient mice contain fewer
CD4
+CD25
+Foxp3
+ regulatory T-cells upon infection with
C. pneumoniae
Several reports indicated that TLR2 influences the expansion
and function of regulatory T-cells and express TLR2 on their cell
surface upon activation with anti CD3 [14]. Additionally, co-
stimulation with the TLR2-ligand Pam3Cys has been shown to
induce their proliferation which is accompanied by a transient loss
of their suppressive activity [14,15]. In vivo, TLR2 was also shown
to be crucial for the expansion of regulatory T-cells in mice
infected with Schistosoma mansoni [16]. Therefore, we analyzed the
frequency of CD4
+CD25
+Foxp3
+ T-cells in lungs of C. pneumoniae-
infected wild type and TLR2/4 double-deficient mice. In mock-
treated mice the percentage of CD4
+CD25
+Foxp3
+ T-cells was
not different in both strains (Fig. 6A, left panels). However, upon
infection the frequency of these cells was almost 3-fold higher in
wild type compared to TLR2/4 double-deficient mice (Fig. 6A
right panels, 6C). Conversely, the percentage of IFNc-producing
CD4
+ T-cells analyzed ex vivo (i.e. the cells were not re-stimulated)
Figure 3. C. pneumoniae-specific CD4
+ T cells are responsible for the enhanced IFNc-response in TLR2/4 double-deficient mice. (A)
Pulmonary cells were prepared from wild type and TLR2/4 double-deficient mice nine days post infection with C. pneumoniae. The cells (1610
5 cells/
well) were then re-stimulated with BMDC (1610
5 cells/well) which were or were not infected with C. pneumoniae (MOI=5). After 1 h of culture
Brefeldin A was added, the culture continued for another 12 h and cells were stained for CD4, CD8 and intracellular IFNc. FACS graphs show the IFNc
response of CD4
+ T-cells. (B) Pulmonary cells from C. pneumoniae-infected wild type (n=3/time point) and TLR2/4 (n=3/time point) double-deficient
mice were prepared at different time points as indicated in the graph. Mock infected animals served as controls (time point 0). Cells were stained with
mAbs specific for CD3, CD4, CD8 and IFNc as described in Materials and Methods and analyzed by flow cytometry. Upper graphs show frequncies,
lower graphs absolute numbers of IFNc
+CD4
+ or CD8
+ T cells. (C) Pulmonary cells were prepared from C. pneumoniae-infected wild type (n=2/time
point) of TLR2/4 double-deficient mice (n=2 6d, n=1 9d, n=12d) after 6, 9, and 12 days post infection and the cells were stained for CD4, CD3 and
IFNc. Note that CD4
+CD3
2 cells hardly contribute to IFNc-secretion.
doi:10.1371/journal.pone.0026101.g003
Figure 4. Enhanced extra-pulmonary IFNc responses in C.
pneumoniae-infected TLR2/4 double-deficient mice. Lung (upper
graph) and spleen cells (lower graph) were prepared nine days post
infection with C. pneumoniae. Subsequently cells (1610
5 cells/well)
were re-stimulated with BMDC (1610
5 cells/well) which were or were
not infected with C. pneumoniae (MOI=5) for three days. The secretion
of IFNc was determined by analyzing the culture supernatant with a
commercially available ELISA-system. The graph represents the data of
three independent experiments. Error bars represent SD of individual
mice (n=3 mock wild type and mock TLR2/4 double deficient mice,
n=5 infected wild type mice, n=4 infected TLR2/4 double-deficient
mice). *p=0.016, Mann-Whitney Rank sum test.
doi:10.1371/journal.pone.0026101.g004
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is an inverse relation between the frequencies of CD4
+
CD25
+Foxp3
+ regulatory T-cells and CD4
+IFNc
+ effector T-cells
(Fig. 6C).
IFNc fails to induce iNOS in C. pneumoniae-infected TLR2/
4 double-deficient BMDMs
Normally, CD4
+IFNc
+ effector T-cells play a protective role
during C. pneumoniae infection [8]. As demonstrated in Fig. 1,
TLR2/4 double deficient mice lost considerably more weight at
day 12 post infection than wild type mice despite increased IFNc
levels. We also demonstrated earlier that these mice displayed a
higher lethality [10]. Therefore, we were interested in the effects of
IFNc on anti-chlamydial defense and investigated the influence of
IFNc on iNOS production in TLR2/4 double-deficient cells. This
enzyme participates in the control of an infection with C.
pneumoniae in vivo as revealed by the analysis of iNOS-deficient
mice [7]. We also examined previously the role of MyD88, the
adapter molecule used by TLR2 and TLR4, in the induction of
iNOS and showed that the level of this enzyme was reduced in
infected MyD88-deficient mice [17]. MyD88-deficient BMDM
failed to release nitric oxide (NO) upon stimulation with C.
pneumoniae and IFNc since two important transcription factors, NF-
kB and AP-1 which participate in the transcriptional regulation of
the nos2 gene, were not induced, while induction of IRF-1 and
phosphorylation of STAT-1 were normal [17]. As we show here,
upon stimulation with IFNc IRF-1 induction is not affected in
TLR2/4 double-deficient macrophages (Fig. 7A). Moreover, prior
infection of the macrophages with C. pneumoniae did not alter the
ability of IFNc to induce IRF-1 in BMDM of both genotypes
(Fig. 7A). As expected, infection of BMDM with C. pneumoniae
degraded IkB in wild type but not in TLR2/4 double-deficient
cells (Fig. 7B). Since NF-kB is crucial for the induction of iNOS
[17], it was not unexpected that the ability of IFNc to induce
iNOS-expression was severely impaired in C. pneumoniae-infected
TLR2/4 double-deficient BMDM (Fig. 7C). Moreover, NO-
secretion was completely abolished (Fig. 7D). Taken together, the
failure of IFNc to induce iNOS presumably contributes to lethality
observed in TLR2/4 double-deficient mice.
Discussion
Using TLR2/4 double-deficient mice we show that TLR2
and TLR4 regulate IFNc-secretion in vivo during pneumonia
caused by C. pneumoniae. Our findings demonstrate that CD4
+
T-cells were responsible for the enhanced IFNc-production, since
CD4
+CD3
+IFNc
+ cells were more frequent in lungs of infected
TLR2/4 double-deficient mice. IFNc-producing CD4
+ T-cells
were antigen-specific, since release of IFNc in vitro required
re-stimulation of the cells with C. pneumoniae-infected BMDC.
Enhanced IFNc-secretion was not confined to CD4
+ T cells
isolated from the infected lungs but was also observed in
lymphocytes prepared from the spleen. Antigen-presenting cells
appeared not to be involved in enhanced IFNc-secretion by
CD4
+ T-cells since BMDC from TLR2/4 double-deficient mice
re-stimulated wild type cells as efficiently as wild type BMDC.
However, upon infection TLR2/4 double-deficient mice displayed
a lower frequency of CD4
+CD25
+Foxp3
+ regulatory T-cells in vivo
and the frequency of regulatory T-cells was inversely related to the
frequency of CD4
+IFNc
+ T-cells. Despite the fact that IFNc was
produced in increased amounts by TLR2/4 double-deficient
CD4
+ T-cells, the cytokine failed to induce NO by BMDM lacking
TLR2 and TLR4.
Previous reports indicated that the TLR key adapter molecule
MyD88 was required for a TH1 CD4
+ T-cell response upon
stimulation of the cells with ovalbumin in complete Freund’s
adjuvant or by endotoxin plus allogeneic cells [11,12]. Our results
show, however, that in the absence of the relevant TLRs, i.e.
TLR2 and TLR4, CD4
+ T-cells can be sensitized to release IFNc
upon infection with C. pneumoniae. In agreement with the data
presented here, infection of MyD88-deficient mice with Mycobac-
terium bovis BCG also triggered CD4
+ T-cells to produce IFNc [13].
While the reasons for these discrepancies are unclear, it is likely
that MyD88-independent recognition systems including NOD-like
receptors also recognize bacteria-derived ligands which are
presumably not present in complete Freund’s adjuvant or in
endotoxin preparations. Based on our previous report, C.
pneumoniae-induced secretion of the cytokines TNF and IFNc and
the chemokines KC and MCP-1 depended on MyD88 three days
post infection. However, six days post infection these cyto- and
chemokines were secreted MyD88-independently [2]. Thus, we
speculate that the complex composition of pathogen-associated
molecular patterns of bacteria allows the MyD88-independent
induction of a TH1-response.
TLR2/4 double-deficient BMDC re-stimulated wild type cells
with the same efficiency as wild type BMDC to produce IFNc.
Although TLR2-deficient BMDC were impaired to secrete TNF
and IL-12p40 upon infection with C. pneumoniae in vitro [9], both
factors were presumably not required for T-cell stimulation.
However, TLR4-deficient BMDC failed to increase the expression
of the co-stimulatory cell surface molecule CD40 upon stimulation
with endotoxin and were unable to stimulate allogeneic T-cells,
while the endotoxin-induced up-regulation of CD40, CD80 and
CD86 was independent from MyD88 [18]. Since the infection of
TLR2/4 double-deficient mice with C. pneumoniae generated even
more CD4
+IFNc
+ T-cells, we conclude that in vivo antigen-
presenting cells are not impaired in their ability to activate
antigen-specific T-cells in the absence of TLR2 and TLR4.
Enhanced IFNc-responses by C. pneumoniae-specific CD4
+ T-
cells in TLR2/4 double-deficient mice are best explained by an
impaired infection-associated expansion of CD4
+CD25
+Foxp3
+
regulatory T-cells. In contrast to MyD88-deficient mice, which
appear to contain reduced numbers of regulatory T-cells [15], the
frequency of these cells in mock-treated TLR2/4 double-deficient
mice was similar to the one in wild type mice. Our results are in
agreement with reports, which show that expansion of Tregs can
be triggered by a co-stimulation of T-cell receptors and TLR2
[14,15]. As we have published earlier, chlamydial heat shock
protein 60 (HSP60, GroEL) triggers cells via TLR2 and TLR4
[19,20,21] and may (together with C. pneumoniae-derived antigens)
Figure 5. Antigen-presentation is not impaired in TLR2/4 double-deficient BMDC. In (A) and (B) lung cells were prepared three days post
infection with C. pneumoniae. The cells were stained with antibodies specific for CD11c, CD86, CD80 or MHC class II. All events are gated on CD11c.
Error bars represent SD of three individual mice. The experiment was repeated once with similar results. (C) Pulmonary cells were prepared from wild
type mice infected nine days earlier with C. pneumoniae. The cells (1610
5 cells/well) were re-stimulated with titrated amounts of BMDC from wild
type or TLR2/4 double-deficient mice as indicated which were or were not infected with C. pneumoniae (MOI=5). The IFNc-content of the culture
supernatant was analyzed by ELISA after three days of culture. Error bars represent SD of three replicate cultures. The experiment was repeated twice
with similar results.
doi:10.1371/journal.pone.0026101.g005
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+CD25
+Foxp3
+ Tregs in
vivo.
Our results also imply that the adaptive TH1 immune response
is unable to prevent the lethal outcome of pulmonary infection
caused by C. pneumoniae, if TLR2 and TLR4 are absent. In
association, previous studies have shown the importance of IFNc-
producing CD4
+ T-cells in increasing resistance of RAG-1/IFNc-
double-deficient mice against an infection with C. pneumoniae [8].
Similar observations were obtained in a model where MyD88-
deficient mice were infected with M. tuberculosis. Vaccination of
MyD88-deficient mice with M. bovis BCG induced IFNc-
producing CD4
+ T-cells in vivo, but the TH1 cells only partially
prevented lethal pneumonia upon challenge with M. tuberculosis
[13]. Upon challenge with C. pneumoniae MyD88-deficient mice
succumbed like TLR2/4-deficient mice to progressive pneumonia
[10], although pulmonary IFNc-levels were increased like in wild
type mice six days post infection [2]. Furthermore, the ability of
IFNc to induce iNOS was impaired in MyD88-deficient
macrophages [17]. Full induction of iNOS required the transcrip-
tion factors AP-1, NF-kB, IRF-1 and STAT-1. The former two
were not activated in MyD88-deficient bone marrow-derived
macrophages (BMDM) upon infection with C. pneumoniae in vitro
leading to a complete failure to induce iNOS. In vivo, iNOS-levels
were considerably reduced in MyD88-deficient mice post infection
with C. pneumoniae. Identical to these published findings we show
here, that in C. pneumoniae-infected TLR2/4 double-deficient
BMDM IFNc only weakly up-regulated the expression of iNOS
and failed to induce the secretion of NO, since the infection of
these cells with C. pneumoniae did not induce NF-kB. INOS is
crucial to control the replication of C. pneumoniae in vivo, since the
chlamydial burden is considerably increased in iNOS-deficient
mice [7]. Thus, although C. pneumoniae-specific CD4
+ T-cells
produce enhanced amounts of IFNc in TLR2/4-deficient mice,
the cytokine cannot completely exert its protective effects in
TLR2/4 double-deficient mice, since it is impaired to induce
iNOS.
In summary, expansion of CD4
+CD25
+Foxp3
+ T-cells is
impaired in C. pneumoniae-infected TLR2/4 double-deficient mice.
This is accompanied by an increased frequency of CD4
+IFNc
+
effector T-cells which cannot prevent lethal pneumonia.
Materials and Methods
Ethic statement
All animal experiments were reviewed and approved by the
local authorities (Regierung von Oberbayern, file number 211-
2531-59/06).
Strains of mice
C3H/HeN mice were purchased from Harlan Winkelmann
GmbH (Borchen, Germany). Breeding pairs of C57BL/6 TLR2
2/2
mice came from Tularik (South San Francisco, CA). They were
backcrossed six times to TLR4
d/d C3H/HeJ mice to generate
TLR2/4 double-deficient mice. The genotype of the mice was
verified phenotypically as described in [21]. Alternatively, TLR2
2/2
mice were crossed with TLR4
2/2 mice and the resulting TLR2/4
double-deficient mice were further backcrossed nine times to C3H/
HeN mice. The genotype of these mice was analyzed by PCR (Fig.
S1). All mice were bred in our own animal facility under specific
pathogen-free conditions.
Reagents
The peroxidase-conjugated AffiniPure F(ab `)2 fragment Donkey
anti-Rabbit IgG (H+L) and peroxidase-conjugated AffiniPure
F(ab `)2 fragment Goat anti-Mouse IgG+IgM (H+L) were purchased
from Dianova (Germany), and the monoclonal antibody to b-actin
was provided by Sigma-Aldrich (Germany). The monoclonal
antibodies specific for IRF-1 (M-20): sc-640, iNOS and IkB (clone
E130) were provided by Santa Cruz Biotechnology, Inc. (CA,
USA), Upstate (Millipore, Germany) and Epitomics (USA),
respectively. Murine IFNc (315-05) was purchased from Peprotech
Inc. (New Jersey, USA).
Infection protocol
Anesthesized mice were infected intranasally with Chlamydia
pneumoniae (CM-1, ATCC VR-1360, 2.5610
6 IFUs). Infected mice
were inspected every day and body weight was determined on day
6 and 9 and 12 post infection.
Generation of BMDC and BMDM
BMDC were generated according to Inaba et al with slight
modification [22]. Mice were sacrificed and tibiae and femora
were removed, cleaned and flushed with cell culture medium.
They were plated on bacterial petri-dishes overnight in culture
medium (RPMI 1640, 10% heat-inactivated FCS, 100 mg/ml
penicillin, 100 mg/ml streptomycin, 5610
25 M 2-ME) to remove
adherent cells. Non-adherent cells were plated at a density of
5610
6 cells/dish, and cultivated for another five days in complete
medium in the presence of GM-CSF (10% v/v). The cells were
counted, plated in medium devoid of FCS and antibiotics and
exposed to C. pneumoniae at a multiplicity of infection (MOI) of 5.
After 30 hours the BMDC were counted and used for re-
stimulation assays.
BMDM were generated according to Rutschman et al. [23].
Briefly, femora and tibiae of mice were rinsed with cell culture
medium applied through a 26-gauge syringe. Bone marrow cells
were cultured in petri dishes at a density of 5610
6 cells/dish in the
presence of L cell-conditioned medium as a source of M-CSF-1
(10% v/v). The medium used was very low endotoxin DMEM
(PAA Laboratories GmbH, Austria) supplemented with 10% FCS
(Biochrom AG, Germany), 2-ME (50 mM; Life Technologies,
Germany) and the antibiotics Vancomycin and Gentamicin, both
provided by Sigma-Aldrich (Germany). Cells were washed
vigorously and only adherent macrophages were used 6–7 days
after plating. FACS analysis showed that these BMDM were F4/
80
+ and CD11b
+ as described previously (data not shown) [10].
Isolation of lung and spleen cells
Mice were sacrificed with CO2 on day 6, 9 or 12 post infection
with C. pneumoniae. Lungs were flushed with 10 ml PBS and
digested after manual mincing. The lungs were digested with
collagenase VIII (400 U/100 ml 10 min at room temperature,
400 U/2 ml RPMI 0% FCS, 30 min at 37uC), washed and
Figure 6. Inverse relation in vivo between the percentage of CD4
+CD25
+Foxp3
+ T-cells and the percentage of CD4
+IFNc
+ T-cells.
Pulmonary cells were prepared from wild type and TLR2/4 double-deficient mice nine days post infection with C. pneumoniae. In (A) the expression of
CD25 on the cell membrane and intracellular Foxp3 was analyzed. All events were gated on CD4. (B) shows the expression of intracellular IFNc by
CD4
+ T-cells ex vivo without re-stimulation. (C) demonstrates the relationship between CD4
+Foxp3
+ and CD4
+IFNc
+ T-cells. Error bars represent SD of
three individual mice. The experiment was repeated twice with similar results.
doi:10.1371/journal.pone.0026101.g006
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PLoS ONE | www.plosone.org 8 November 2011 | Volume 6 | Issue 11 | e26101Figure 7. IFNc is severely impaired to increase iNOS expression and fails to release NO in C. pneumoniae-infected TLR2/4 double-
deficient BMDMs. (A) Wild type or TLR2/4 double-deficient BMDMs (7.5610
5 cells/well) were left untreated, or stimulated with IFNc (10 ng/ml) for
24 h, or were infected with C. pneumoniae (MOI=10, for 48 h), or were infected with C. pneumoniae for 48 h and treated with IFNc 24 h post
infection. IRF-1 was detected by Western blot, detection of b-actin was used as loading control. (B) Wild type or TLR2/4 double-deficient BMDMs
(7.5610
5 cells/well) were or were not infected with C. pneumoniae (MOI=10) for the time periods indicated in the graph. IkB was detected by
Western blot, detection of b-actin was used as loading control. (C) Wild type or TLR2/4 double-deficient BMDMs were treated as described in (A). iNOS
was determined by Western blot, detection of b-actin was used as loading control. (D) Wild type or TLR2/4 double-deficient BMDMs (7.5610
5 cells/
well) were left untreated, or stimulated with IFNc (10 ng/ml) for 48 h, or were infected with C. pneumoniae (MOI=10, for 72 h), or were infected with
C. pneumoniae for 72 h and treated with IFNc 48 h post infection. Subsequently, NO-levels were determined in the culture supernatant. Error bars
represent SD of four or in the case of untreated samples of two individual cultures. *not detectable. The experiment was repeated once with similar
results.
doi:10.1371/journal.pone.0026101.g007
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single cell suspension was prepared. Erythrocytes were lysed with
ammonium chloride (0.15 M, 5 min, RT) and washed subse-
quently with PBS containing 3% FCS. Co-cultures for intracellular
staining were performed with 4610
6 lung cells and 1610
6 BMDC
for 13 h. Brefeldin A (Golgi-Plug, BD Biosciences, San Jose, CA,
USA) was added for the last 12 h of culture. For long-term
cultures, 1610
5 pulmonary or spleen cells and 1610
5 BMDC were
co-cultured in 96-well plates.
Determination of IFNc levels
IFNc levels were determined using a commercially available
ELISA system (DuoKit BD Biosciences). The assay was performed
according to manufacturer’s manual. Data were analyzed using
SigmaPlot 10.0 (Systat Software, Inc.).
Flow cytometry
Cells were counted and concentrated to 2610
6 cells per ml.
Cells were washed with PBS (3% FCS) and pre-incubated with
EMA (2 mg/ml, 20 min 4uC, Molecular Probes, OR, USA) to
exclude dead cells and anti-CD16/32 (10 mg/ml, 10 min, 4uC,
Caltag Laboratories, Invitrogen, Carlsbad, CA, USA) to block Fc-
receptors. Cells were stained with different combinations of APC-
or PE-labelled mAb specific for CD3, APC-labelled mAb directed
against CD8 (2 mg/ml, Caltag Laboratories) and PE-labelled mAb
directed against CD4 (2 mg/ml, Caltag Laboratories) for 30 min
on ice. The cells were washed again and then fixed and
permeabilized with Perm/Wash (BD Biosciences, San Jose, CA,
USA) for 20 min on ice. After another wash step intracellular
staining was performed with FITC-labelled mAb directed against
IFNc (1 mg/ml, BD) for 30 min on ice. Cells were washed with
Perm/Wash (BD) twice and fixed again with 2% paraformalde-
hyde.
To detect regulatory CD4
+ T-cells, cells were also stained with a
mAb specific for CD25 (5 mg/ml, 30 min, 4uC, BD) and with a
mAb specific for Foxp3 (clone FJK-16 s, eBioscience, Frankfurt,
Germany) using the Foxp3 Staining Buffer Set from eBioscience
(00-5523-00) according to the manufacturer’s recommendations.
The induction of co-stimulatory molecules on CD11c
+ pulmo-
nary cells was analyzed by staining the cells with antibodies
specific for CD11c (2 mg/ml, Caltag Laboratories), CD80 (5 mg/
ml, BD), CD86 (2 mg/ml, BD) and MHC class II molecules I-A/I-
E( 5mg/ml, BD).
Flow cytometry was performed with a Calibur instrument (BD
Biosciences, San Jose, CA, USA), the data were analyzed using the
FloJo software (Three Star Inc, OR, USA).
Cell lysis, SDS-PAGE and Western blotting
Cell extracts were prepared for Western blotting using RIPA
buffer (20 mM Tris pH 7.5, 150 mM NaCl, 1% NP-40, 0,5%
Sodium Deoxycholate, 1 mM EDTA, 0,1% SDS) which was
supplemented with Sodium Orto-Vanadat (Sigma-Aldrich, Ger-
many) and a protease inhibitor cocktail (Roche Diagnostics
GmbH, Germany). Cell lysates were clarified by sonication and
centrifugation before electrophoresis. Proteins were separated by
SDS-PAGE (10% acrylamide) in TANK Buffer (25 mM Tris,
0.2 M glycine, 0.1% SDS), using Laemmli buffer (62.5 mM Tris,
50% glycerol, 2% SDS, 2 mM EDTA) for sample loading. After
transfer to nitrocellulose membrane by semidry electroblotting for
1.5 h (2 mA/cm
2) in Transfer Buffer (25 mM Tris, 250 mM
Glycine, 20% Methanol, 0,35% SDS), membranes were blocked
in TBST (2.4 g/l Tris, 8 g/l NaCl, 0.1% Tween, pH 7.6,
containing 5% milk powder, 2 h, room temperature). Thereafter,
membranes were incubated with antibodies specific for iNOS
(diluted 1:1000), IRF-1 (diluted 1:500), IkB (diluted 1:5000) and b-
actin (diluted 1:20000). All primary antibodies were incubated
overnight at 4uC. After three washing steps with TBST the
secondary antibody was added (diluted 1:8000 in TBST
containing 5% milk powder, 2 h, room temperature). The blot
was washed again three times with TBST and visualized using the
Western lightning
TM- Chemiluminiscence Reagent (Perkin Elmer
LAS Inc, MA, USA) as described by the manufacturer.
Nitrite measurement
Nitrite production was measured from wild type and TLR2/4
double-deficient BMDM supernatants. Briefly, the cells were
cultured in 12-well plates in 1 ml of culture medium until
confluence. The cells were stimulated with IFNc or C. pneumoniae
and the culture supernatants were collected. Nitrite was measured
by adding 50 ml of Griess reagent (1% sulfanilamide and 0.1%
naphthylethylenediamide in 5% phosphoric acid) to 50 ml samples
of culture medium. The optical density at 550 nm (OD550) was
measured using a microplate reader and the nitrite concentration
calculated by comparison with the OD550 produced using
standard solutions of sodium nitrite in the culture medium.
Statistics
Comparison of two equally treated groups was analyzed by
Mann-Whitney Rank sum test. More than two equally treated
groups were tested for significant differences with one way
ANOVA, post hoc test Holm-Sidak. Statistical analysis was
performed with SigmaStat (SPSS Inc., IL, USA).
Supporting Information
Figure S1 Identification of TLR2/4 double-deficient
mice. Genomic tail DNA was prepared from 19 mice bred from
a cross of TLR2- or TLR4-deficient mice. Primer sequences used
were as follows: TLR2 WT1 59-CTTCCTGAATTTGTCCAG-
TACAGG-39 TLR2 WT2 59-TCGACCTCGATCAACAGGA-
GAAGGG-39 TLR2 KO 59-GGGCCAGCTCATTCCTCCC-
ACTCAT-39 TLR4 WT1 59-GTTTAGAGAATCTGGTGGC-
TGTGGAGAC-39 TLR4 WT2 59-TATATG CGGCCGCT-
CATCTGC TGTACTTTTTACAGCC-39 TLR4 KO59-TGT-
TGGGTCGTTTGTTCGGATCCGTCG-39. PCR amplification
using primers TLR2 WT1 and TLR2 WT2, or TLR2 WT1 and
TLR2 KO, or TLR4 WT1 and TLR4 WT2, or TLR4 WT1 and
TLR4 KO detected the wild type TLR2 gene, TLR2-deficiency,
the wild type TLR4 gene or TLR4-deficiency, respectively. The
different PCRs were run with slight variations (details upon
request): 94–95uC180–300 s 94–95uC 30–60 s 59–67uC 30–
60 s30 cycles 70–74uC 60–180 s 72uC120 s 4uC.
(TIF)
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